${ slideshowObject ? slideshowObject.selectedIndex + 1 : 1 } 4

Untitled Design (19)

Thank you

Thank you, your message has been successfully sent. You will receive an email confirmation shortly.

Untitled Design (19)

Picture1 (1)

Open Now

Pure Skin Medical

6 Years of Experience

Open Now

PureSkin is located in Marylebone, adjacent to Bond Street and Selfridge. It was co-founded by a team of top NHS medical experts. The team members have more than 20 years of medical and plastic surgery-related experience, dedicated to infusing beauty and professionalism into every customer who comes for consultation and aesthetic surgery, creating a customised and comprehensive medical cosmetic surgery program.

We have a professional and high-quality medical team. The team members are from the forefront of the British National Health System (NHS). Each of our aesthetic doctors has more than 20 years of professional medical experience and is registered and filed in the General Medical Council (GMC), Nursing and Midwifery Council (NMC), and the General Dentist Council (GDC). We are committed to using frontier technology and professional techniques and attitudes to add points to your beauty. At the same time, our clinic and doctors are covered by medical beauty insurance to escort your beauty journey with the best care. Contact us today to find out more.

Accreditations

HARLEY ACADEMY ACCREDITED COSMETIC TRAINING

1

Languages offered

English

Treatments offered

Ellansé

Collagen Stimulators

Thread Lifts

Anti-Wrinkle Treatments

Mesotherapy

PRP

Medical Grade Peels

Dermal Fillers for Hands

Laser Hair Removal

Untitled Design (19)

Address

Pure Skin Medical
11 Welbeck Street
London
W1G 9XZ

Contact Us

Social Media

Opening hours

Monday

11:00 - 17:00

Tuesday

11:00 - 17:00

Wednesday

11:00 - 17:00

Thursday

11:00 - 17:00

Friday

11:00 - 17:00

Saturday

11:00 - 17:00

Sunday

Closed

Thank you, your message has been successfully sent. You will receive an email confirmation shortly.

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

Important Safety Considerations:

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising.

Other potential adverse events include

- Injection related reactions, include itching, discoloration or tenderness may occur at the site of the injection. These usually resolve spontaneously within several days after the injection.

- As with any implant material possible adverse reactions that may occur include, but are not limited to the following: hypersensitivity, allergic reactions, inflammation, infection, fistula formation, haematoma, seroma, extrusion, induration formation, inadequate healing, skin discoloration, oedema, contusions/bruises, ecchymosis, inadequate or excessive augmentation, loss of correction, interference with local circulation if injected into a blood vessel resulting in vessel laceration, occlusion, embolism, infarction, and abscess at implant site which may result in induration and/or scar formation.

- Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, damage to underlying facial structures, nausea and vomiting, lack of ocular movement, significant skin changes, ptosis, exotropia and neurological complications.

- Adverse events, other than mentioned above, could occur as can be with any medical intervention.

All (potential) adverse side effects and incidents should be reported immediately to the Sinclair Corporate Safety Group: quality@sinclair.com

For a full list of contraindications, warnings, and precautions for this product please visit http://www.sinclairpharma.com/eifu/ for a copy of the Product Instructions for Use.